Laura Cervino, PhD

Attending Physicist, Chief of Radiotherapy Physics Service

Laura Cervino, PhD

Attending Physicist, Chief of Radiotherapy Physics Service
Laura Cervino


PhD, MSc, in aerospace engineering, University of California, San Diego; BSc in aeronautical engineering, Universidad Politecnica de Madrid, Spain

I was born and raised in Spain and have a background in aeronautical engineering. After my undergraduate studies, I came to the US to pursue graduate studies. I completed my PhD in mechanical and aerospace engineering at the University of California, San Diego, followed by a postdoctoral fellowship in radiology and radiation oncology. 

I joined the Medical Physics faculty at UC San Diego in 2009 where I was the Breast and Gynecological Cancers Physics Service Chief and the Assistant Vice Chair for Diversity. I recently moved to MSK as the Chief of the Radiotherapy Physics Service in the Department of Medical Physics. 

I have a strong clinical and research interest in image-guided radiation therapy, motion management, patient safety, and automation.


Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Laura Cervino discloses the following relationships and financial interests:

  • Arquimea Group, S.L
    Professional Services and Activities (Uncompensated)

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures